SCHEMBL4435678

SCHEMBL4435678

O=CC1CCNC(Cc2ccccc2)(C(=O)O)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.40
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
HSD11B1 P28845 1/20 0.33
CYP3A4 P08684 1/20 0.33
ARG1 P05089 1/20 0.33
ARG2 P78540 1/20 0.33
MAPK1 P28482 1/20 0.33
EPHX2 P34913 1/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
DDB1 Q16531 1/20 0.32
CRBN Q96SW2 1/20 0.32
GRIN2B Q13224 2/20 0.32
MAPT P10636 1/20 0.32
MAOA P21397 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6211749 0.78 HRH3 (0.40) HRH3SLC6A2SLC6A4SLC6A3HSD11B1
SCHEMBL17274417 0.74 HRH3 (0.37) HRH3SLC6A2SLC6A4SLC6A3CYP3A4
SCHEMBL414249 0.72 SLC6A2 (0.56) HRH3SLC6A2SLC6A4SLC6A3ARG1
SCHEMBL10956783 0.72 SLC6A2 (0.56) HRH3SLC6A2SLC6A4SLC6A3ARG1
SCHEMBL440476 0.72 SLC6A2 (0.56) HRH3SLC6A2SLC6A4SLC6A3ARG1
Hydrochloric Acid SCHEMBL7375378 0.71 SLC6A2 (0.55) HRH3SLC6A2SLC6A4SLC6A3ARG1
SCHEMBL8083651 0.71 SLC6A2 (0.52) HRH3SLC6A2SLC6A4SLC6A3ARG1
SCHEMBL7455945 0.71 SLC6A2 (0.52) HRH3SLC6A2SLC6A4SLC6A3ARG1
SCHEMBL11184730 0.68 HRH3 (0.36) HRH3SLC6A2SLC6A4SLC6A3
SCHEMBL6830859 0.67 LMNA (0.40) HRH3SLC6A2SLC6A4SLC6A3HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2134693-A2 METALLOPROTEASE INHIBITORS CONTAINING A HETEROCYCLIC MOIETY Alantos Pharmaceuticals Holding, Inc. (US) 2009-12-23 EP disclosed
WO-2008109181-A2 METALLOPROTEASE INHIBITORS CONTAINING A HETEROCYCLIC MOIETY ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2008-09-12 WO disclosed